Kimberly-Clark Corp (N:KMB)

Business Focus: Sanitary Products

Sector:  Consumer Non-Cyclicals Industry:  Personal Products
 
See Regulatory Filings on SEC
Company Contact
Address: 351 Phelps Dr
IRVING TX 75038-6507
Tel: N/A
Website: https://www.kimberly-clark.com/en-us
IR: See website
<
Key People
Michael D. Hsu
Chairman of the Board, Chief Executive Officer
Tamera Fenske
Senior Vice President, Chief Supply Chain Officer
Nelson Urdaneta
Chief Financial Officer, Senior Vice President
Ehab Abou-Oaf
President of K-C Professional
Doug Stuart Cunningham
President, K-C Europe, Middle East & Africa
Russell Torres
Group President, K-C North America
Gonzalo Uribe
President, K-C Latin America
Tristram Otto Wilkinson
President, K-C Asia Pacific
Sandra R.A. Karrmann
Chief Human Resource Officer, Senior Vice President
Grant Mcgee
Senior Vice President, General Counsel
   
Business Overview
Kimberly-Clark Corporation is principally engaged in the manufacturing and marketing of a range of products made from natural or synthetic fibers and materials using advanced technologies in fibers, nonwovens and absorbency. The Company has three segments. Personal Care segment offer solutions and products, such as disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear and other related products. Products in this segment are sold under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex and other brand names. Consumer Tissue segment offers facial and bathroom tissue, paper towels, napkins and related products, and are sold under the Kleenex, Scott, Cottonelle, Andrex, Viva, Scottex and other brand names. K-C Professional segment offers wipers, tissue, towels, personal protective equipment, soaps and sanitizers under the Kleenex, Scott, WypAll, Kimtech and KleenGuard brand name.
Financial Overview
For the three months ended 31 March 2024, Kimberly-Clark Corp revenues decreased 1% to $5.15B. Net income increased 14% to $647M. Revenues reflect Consumer Tissue segment decrease of 2% to $1.6B, K-C Professional segment decrease of 3% to $823M, Outside North America segment decrease of 5% to $2.4B. Net income reflects Personal Care segment income increase of 12% to $545M, Consumer Tissue segment income increase of 21% to $290M.
Employees: 41,000 as of Dec 31, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $53,563M as of Mar 31, 2024
Annual revenue (TTM): $20,385M as of Mar 31, 2024
EBITDA (TTM): $3,819M as of Mar 31, 2024
Net annual income (TTM): $1,845M as of Mar 31, 2024
Free cash flow (TTM): $1,013M as of Mar 31, 2024
Net Debt Last Fiscal Year: $7,143M as of Mar 31, 2024
Shares outstanding: 336,800,000 as of Mar 31, 2024
Index Membership: S&P 500
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.